Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

7(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Detailed Status

Completed5

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 1

Trials by Phase

Phase 17 (100.0%)

Trials by Status

terminated114%

withdrawn114%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_1

Phase1, STP7 Cocaine Drug-Drug Interaction Study

NCT06273540

completedphase_1

Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans

NCT02018263

completedphase_1

Clinical Trials (7)

Showing 7 of 7 trials

NCT06273540Phase 1

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Completed

NCT02018263Phase 1

Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans

Completed

NCT01978431Phase 1

Impulsivity and Stimulant Administration

Completed

NCT02302976Phase 1

GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration

Completed

NCT01978457Phase 1

Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction

Terminated

NCT00338546Phase 1

Study to Improve Scientific Understanding of the Cardiovascular Actions of Cocaine

Withdrawn

NCT01137890Phase 1

Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7